Compounds > triazoles
Page last updated: 2024-08-24

triazoles and Retinal Diseases

triazoles has been researched along with Retinal Diseases in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (40.00)18.2507
2000's1 (10.00)29.6817
2010's5 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hambly, R; Lally, A1
Ishibashi, T; Oshima, Y; Sonoda, KH; Takeda, A; Yang, Y; Yoshimura, T; Zhang, H1
Walia, HS; Yan, J1
Feucht, N; Hadeler, J; Lanzl, I; Loos, D; Schmid, RM; Schwerdtfeger, C; Spinner, CD1
Deghedy, MR; Ebeid, WM; El-Shazly, AA; Elkitkat, RS1
Crewther, D; Crewther, S; Kiely, P; Kowal, L; Luu, C1
Bonhomme, B; Braquet, P; Cluzel, J; Doly, M; Millerin, M2
Cluzel, J; Doly, M; Droy-Lefaix, MT; Menerath, JM1
Bonhomme, B; Braquet, P; Doly, M; Droy-Lefaix, MT; Millerin, M1

Other Studies

10 other study(ies) available for triazoles and Retinal Diseases

ArticleYear
Hydroxychloroquine toxicity and aromatase inhibitors.
    The British journal of dermatology, 2017, Volume: 177, Issue:3

    Topics: Anastrozole; Aromatase Inhibitors; Dermatologic Agents; Drug Synergism; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Lupus Erythematosus, Discoid; Middle Aged; Nitriles; Retinal Diseases; Triazoles

2017
A Novel Platelet-Activating Factor Receptor Antagonist Inhibits Choroidal Neovascularization and Subretinal Fibrosis.
    PloS one, 2013, Volume: 8, Issue:6

    Topics: Animals; Azepines; Choroidal Neovascularization; Disease Models, Animal; Female; Fibrosis; Hematologic Agents; Lasers; Macrophages; Mice, Inbred C57BL; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Retinal Diseases; RNA, Messenger; Triazoles

2013
Reversible retinopathy associated with oral deferasirox therapy.
    BMJ case reports, 2013, Jul-17, Volume: 2013

    Topics: Administration, Oral; Adolescent; Anemia, Sickle Cell; Benzoates; Deferasirox; Female; Humans; Iron Chelating Agents; Retinal Diseases; Triazoles; Visual Acuity

2013
[Ophthalmological alterations at the initial diagnosis of HIV infection].
    Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2014, Volume: 111, Issue:7

    Topics: Adenine; Adult; Antiretroviral Therapy, Highly Active; Cyclohexanes; Deoxycytidine; Drug Therapy, Combination; Early Diagnosis; Emtricitabine; Eye Infections, Viral; HIV Infections; Humans; Lopinavir; Male; Maraviroc; Organophosphonates; Retinal Diseases; Syndrome; Tenofovir; Treatment Outcome; Triazoles; Zidovudine

2014
ELECTRORETINOGRAPHIC AND VISUAL-EVOKED POTENTIAL CHANGES IN RELATION TO CHELATION MODALITY IN CHILDREN WITH THALASSEMIA.
    Retina (Philadelphia, Pa.), 2017, Volume: 37, Issue:6

    Topics: Administration, Oral; Adolescent; Benzoates; Cross-Sectional Studies; Deferasirox; Deferoxamine; Dose-Response Relationship, Drug; Electroretinography; Evoked Potentials, Visual; Eye Diseases; Female; Humans; Iron Chelating Agents; Male; Optic Nerve; Retina; Retinal Diseases; Retrospective Studies; Siderophores; Thalassemia; Treatment Outcome; Triazoles; Visual Acuity

2017
Central and peripheral vision loss associated with nefazodone usage.
    Documenta ophthalmologica. Advances in ophthalmology, 2003, Volume: 106, Issue:3

    Topics: Adult; Antidepressive Agents, Second-Generation; Color Perception; Electroretinography; Evoked Potentials, Visual; Female; Humans; Piperazines; Retina; Retinal Diseases; Triazoles; Vision Disorders; Visual Acuity; Visual Fields

2003
Protective effect of a specific PAF antagonist on vincristine-induced experimental retinopathy.
    Acta ophthalmologica Scandinavica, 1995, Volume: 73, Issue:2

    Topics: Animals; Azepines; Dark Adaptation; Electroretinography; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Retina; Retinal Diseases; Thienopyridines; Triazoles; Vincristine

1995
Prevention of chloroquine-induced electroretinographic damage by a new platelet-activating factor antagonist, BN 50730.
    Ophthalmic research, 1993, Volume: 25, Issue:5

    Topics: Animals; Azepines; Chloroquine; Dark Adaptation; Electroretinography; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Retina; Retinal Diseases; Tetrazoles; Thienopyridines; Triazoles

1993
Experimental electroretinographic exploration of retinal ischemia: preventive use of free radical scavengers and anti-PAF agents.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 1997, Volume: 13, Issue:1

    Topics: Analysis of Variance; Animals; Azepines; Dark Adaptation; Disease Models, Animal; Electroretinography; Free Radical Scavengers; Ginkgo biloba; Ischemia; Plant Extracts; Platelet Aggregation Inhibitors; Random Allocation; Rats; Rats, Sprague-Dawley; Retinal Diseases; Thienopyridines; Triazoles

1997
Inhibition of vincristine-induced retinal impairments by a specific PAF antagonist.
    Lens and eye toxicity research, 1992, Volume: 9, Issue:3-4

    Topics: Animals; Azepines; Electroretinography; Organ Culture Techniques; Perfusion; Photic Stimulation; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Retinal Diseases; Tetrazoles; Thienopyridines; Triazoles; Vincristine

1992